Adam Grossman is the founder of ADMA Biologics. Based in Hackensack, United States.
Adam S. Grossman is the founder, director, president, and CEO of ADMA Biologics, a company focused on developing plasma-based biologics for infectious disease treatment and prevention. As of June 2025, his estimated net worth was at least $67 million, with holdings of over 3.7 million shares in ADMA Biologics Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library